Physician Wealth Advisors’s iShares iBonds Dec 2026 Term Corporate ETF IBDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$57.6K Sell
2,375
-1,445
-38% -$35K 0.01% 425
2026
Q2
$92.6K Hold
3,820
– – 0.01% 321
2026
Q1
$92.6K Sell
3,820
-3,240
-46% -$78.5K 0.01% 296
2025
Q4
$171K Hold
7,060
– – 0.02% 217
2025
Q3
$172K Hold
7,060
– – 0.02% 213
2025
Q2
$171K Hold
7,060
– – 0.03% 206
2025
Q1
$171K Buy
7,060
+2,170
+44% +$52.4K 0.03% 195
2024
Q4
$118K Buy
+4,890
New +$118K 0.02% 237

Other funds holding IBDR

Physician Wealth Advisors's IBDR Position: Q3 2026 in Review

Physician Wealth Advisors reduced its iShares iBonds Dec 2026 Term Corporate ETF (IBDR) stake by 38% in Q3 2026, selling an estimated $35K and leaving 2,375 shares worth $57.6K. The position accounts for 0.01% of the portfolio, ranked #425.

Physician Wealth Advisors first reported a position in IBDR in Q4 2024 and has held it in 8 quarters since. The position peaked at $172K in Q3 2025. 385 funds tracked by Wall St. Rank hold IBDR as of Q3 2026.

  • Physician Wealth Advisors held 2,375 shares of iShares iBonds Dec 2026 Term Corporate ETF worth $57.6K as of Q3 2026.
  • Physician Wealth Advisors sold 1,445 iShares iBonds Dec 2026 Term Corporate ETF shares in Q3 2026, an estimated $35K.
  • iShares iBonds Dec 2026 Term Corporate ETF made up 0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #425 holding.
  • Physician Wealth Advisors first reported a position in iShares iBonds Dec 2026 Term Corporate ETF in Q4 2024 and has held it in 8 quarters since.
  • Physician Wealth Advisors's iShares iBonds Dec 2026 Term Corporate ETF position peaked at $172K in Q3 2025.
  • 385 funds tracked by Wall St. Rank held iShares iBonds Dec 2026 Term Corporate ETF as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.